Octapharma Research Site

New Haven, Connecticut 06510

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Significant Bleeding Risk Clinical Trial
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
New Haven, CT
Click here to add this to my saved trials